C0338656||Cognitive impairment
C0019682||human immunodeficiency virus
C0220847||hepatitis C virus
C0275524||co-infected
C0282443||review
C0920317||meta-analysis
C0338656||Cognitive impairment
C0019682||human immunodeficiency virus
C0019682||human immunodeficiency virus
C0220847||hepatitis C virus
C0220847||hepatitis C virus
C3714514||mono-infections
C0019682||human immunodeficiency virus
C0220847||hepatitis C virus
C0275524||co-infection
C0282443||review
C0338656||cognitive impairment
C0019682||human immunodeficiency virus
C0220847||hepatitis C virus
C0275524||co-infection
C0332128||examine
C0392335||cognitive performance
C0019682||human immunodeficiency virus
C0220847||hepatitis C virus
C0019682||human immunodeficiency virus
C0220847||hepatitis C virus
C3714514||mono-infected
C0220908||screened
C0282443||review
C2603343||studies
C0920317||meta-analysis
C2603343||studies
C0019682||human immunodeficiency virus
C0220847||hepatitis C virus
C0275524||co-infected
C0338656||cognitive impairment
C0019682||human immunodeficiency virus
C3714514||mono-infected
C0920317||Meta-analysis
C0019682||human immunodeficiency virus
C3714514||mono-infected
C0275524||co-infected
C0275524||co-infected
C0338656||impaired
C0019682||human immunodeficiency virus
C3714514||mono-infected
C0243095||findings
C2603343||studies
C0451331||neuropsychological batteries
C0035648||risk factors
C0042776||viruses
C0392335||cognitive function
C0338656||cognitive impairments
C0805586||challenges
C2364172||medication adherence
C0018727||planning
C0018726||implementation
C1516615||clinical management
C3714514||infections